New drug offers hope for kidney patients suffering from unbearable itching

NCT ID NCT05885737

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 26 times

Summary

This study tested a drug called difelikefalin in 260 Chinese adults on hemodialysis who had moderate-to-severe itching. Participants received either the drug or a placebo for 12 weeks, with an optional 14-week extension. The main goal was to see if the drug reduced itching intensity, measured by a daily 0-10 scale. Results showed improvement in itch scores compared to placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UREMIC PRURITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigator Site 01

    Beijing, China

  • Investigator Site 02

    Lanzhou, China

  • Investigator Site 03

    Nanjing, China

  • Investigator Site 04

    Ürümqi, China

  • Investigator Site 06

    Guangzhou, China

  • Investigator Site 07

    Beijing, China

  • Investigator Site 08

    Shihezi, China

  • Investigator Site 10

    Nanjing, China

  • Investigator Site 11

    Yangzhou, China

  • Investigator Site 12

    Jiaxing, China

  • Investigator Site 13

    Xiamen, China

  • Investigator Site 15

    Xianyang, China

  • Investigator Site 16

    Shenzhen, China

  • Investigator Site 17

    Wuhan, China

  • Investigator Site 18

    Shenyang, China

  • Investigator Site 19

    Nanjing, China

  • Investigator Site 20

    Taiyuan, China

  • Investigator Site 21

    Shenyang, China

  • Investigator Site 22

    Xining, China

  • Investigator Site 23

    Zhengzhou, China

  • Investigator Site 24

    Taiyuan, China

  • Investigator Site 25

    Baotou, China

  • Investigator Site 26

    Changsha, China

  • Investigator Site 29

    Yinchuan, China

  • Investigator Site 30

    Yibin, China

  • Investigator Site 31

    Zhenjiang, China

  • Investigator Site 32

    Shijiazhuang, China

  • Investigator Site 33

    Wuxi, China

  • Investigator Site 34

    Mianyang, China

  • Investigator Site 35

    Zhuzhou, China

  • Investigator Site 36

    Nantong, China

  • Investigator Site 38

    Xinxiang, China

  • Investigator Site 39

    Tianjin, China

  • Investigator Site 40

    Shanghai, China

  • Investigator Site 41

    Shijiazhuang, China

Conditions

Explore the condition pages connected to this study.